MEDICAL CITY PLANO
Plano, TX · CCN 450651 · Rates published
2,195,767 of 2,265,716 rate rows are consumer-grade (96.9%)
69,949 rows are marked excluded from the consumer medians — these stay visible in the raw drill-down with the same reason shown here, so nothing is silently hidden.
| Excluded — reason | Rows |
|---|---|
| no usable negotiated amount (only an out-of-band fallback) — excluded from medians | 24,475 |
| percent-of-billed methodology on a DRG bundle — not comparable to case rates; shown as context only | 19,768 |
| per-diem day rate — not a per-procedure price | 14,259 |
| template filing: same amount across many unrelated codes — excluded | 10,035 |
| below 25% of the Medicare reference for this code — likely a mislabeled per-diem or placeholder; excluded from medians | 1,130 |
| placeholder amount (≤ $0.02) — excluded from medians | 236 |
| exceeds 10× this hospital's gross charge — excluded from medians | 40 |
| below 25% of the Medicare reference for this DRG — likely a mislabeled per-diem; excluded from rankings | 6 |
| Source MRF file | https://stctrprodsnsvc00455826e6.blob.core.windows.net/pt-final-posting-files/62-1682203_MEDICAL-CITY-PLANO_standardcharges.json?si=pt-json-access-policy&spr=https&sv=2024-11-04&sr=c&sig=o5IofreS%2F7ETlsnhPakPWCwHVVUZRobywQ5wUKGjVuQ%3D |
|---|---|
| Found on page | https://medicalcityhealthcare.com/about/legal/pricing-transparency-cms-required-file-of-standard-charges.dot |
| Discovered via | Discovered by HANK |
| Last fetch | Latest re-check couldn't be parsed — showing last good data · 2026-10-03 |
| Content fingerprint | 0e7b99a2e64a061a… · 993,104,970 bytes · first seen 2026-05-09 |
Top 50 most expensive offerings
Outliers are flagged where this hospital's filed rate is ≥2× or ≤0.5× the national median for the same code.
| Code | Description | Payers | Min $ | Max $ | Avg median | vs national |
|---|---|---|---|---|---|---|
|
J3393 HCPCS |
Injection, Betibeglogene Autotemcel, Per Treatment | 1 | $4,850,948.67 | $4,850,948.67 | $4,850,948.67 |
nat. median $2,994,107 1.6× median |
|
845 OTHER |
Inj, Atidarsagene Autotem | 20 | $5,373.81 | $4,955,500.00 | $4,535,408.75 |
nat. median $17,156 outlier · 264.4× |
|
00845 OTHER |
Inj, Atidarsagene Autotem | 2 | $4,369,850.00 | $4,505,000.00 | $4,437,425.00 |
nat. median $4,414,900 1.0× median |
|
J3399 HCPCS |
Injection, Onasemnogene Abeparvovec-xioi, Per Treatment, Up To 5x10°15 Vector Ge… | 1 | $4,271,819.03 | $4,271,819.03 | $4,271,819.03 |
nat. median $2,467,386 1.7× median |
|
J3392 HCPCS |
Injection, Exagamglogene Autotemcel, Per Treatment | 1 | $3,847,800.00 | $3,847,800.00 | $3,847,800.00 |
nat. median $2,401,965 1.6× median |
|
9138 OTHER |
Inj, Hemgenix, Per Tx Dos | 21 | $3,666,840.67 | $4,790,847.10 | $3,740,546.00 |
nat. median $3,758,972 1.0× median |
|
09138 OTHER |
Inj, Hemgenix, Per Tx Dos | 2 | $3,574,708.99 | $3,685,267.00 | $3,629,988.00 |
nat. median $3,574,709 1.0× median |
|
714 OTHER |
Inj Delandistrogene Mox R | 24 | $6,320.33 | $4,991,790.00 | $3,460,974.40 |
nat. median $3,325,455 1.0× median |
|
908 OTHER |
Topi Adm Prad Zami Per Tr | 21 | $9,730.05 | $4,336,566.00 | $3,385,857.30 |
nat. median $30,519 outlier · 110.9× |
|
748 OTHER |
Inj, Lovotibeglogene Auto | 24 | $12,030.68 | $4,878,762.00 | $3,382,608.32 |
nat. median $3,252,508 1.0× median |
|
00908 OTHER |
Topi Adm Prad Zami Per Tr | 2 | $3,235,745.40 | $3,335,820.00 | $3,285,782.70 |
nat. median $14,890 outlier · 220.7× |
|
00714 OTHER |
Inj Delandistrogene Mox R | 2 | $3,228,024.20 | $3,327,860.00 | $3,277,942.10 |
nat. median $3,228,024 1.0× median |
|
906 OTHER |
Inj Elivaldogene Autoteme | 22 | $8,597.64 | $4,770,000.00 | $3,275,400.00 |
nat. median $25,059 outlier · 130.7× |
|
00748 OTHER |
Inj, Lovotibeglogene Auto | 2 | $3,154,932.76 | $3,252,508.00 | $3,203,720.38 |
nat. median $3,187,420 1.0× median |
|
00906 OTHER |
Inj Elivaldogene Autoteme | 2 | $3,084,600.00 | $3,180,000.00 | $3,132,300.00 |
nat. median $3,084,600 1.0× median |
|
746 OTHER |
Inj, Betibeglogene Autote | 24 | $11,128.50 | $4,409,953.50 | $3,057,567.76 |
nat. median $2,939,969 1.0× median |
|
00746 OTHER |
Inj, Betibeglogene Autote | 2 | $2,851,769.93 | $2,939,969.00 | $2,895,869.46 |
nat. median $2,878,960 1.0× median |
|
9141 OTHER |
Inj Onase Abepar-xioi Tre | 24 | $2,455,110.00 | $4,919,063.90 | $2,718,430.05 |
nat. median $2,588,981 1.0× median |
|
09141 OTHER |
Inj Onase Abepar-xioi Tre | 2 | $2,511,311.57 | $2,588,981.00 | $2,550,146.29 |
nat. median $2,511,312 1.0× median |
|
Q2057 HCPCS |
Afamitresgene Autoleucel, Including Leukapheresis And Dose Preparation Procedure… | 2 | $1,271,523.00 | $4,067,128.80 | $2,528,215.20 |
nat. median $813,967 outlier · 3.1× |
|
824 OTHER |
Inj, Exagamglogene Autote | 26 | $13,031.19 | $4,617,360.00 | $2,425,280.00 |
nat. median $2,285,360 1.1× median |
|
00824 OTHER |
Inj, Exagamglogene Autote | 2 | $2,262,040.00 | $2,332,000.00 | $2,297,020.00 |
nat. median $2,285,360 1.0× median |
|
Q2058 HCPCS |
Obecabtagene Autoleucel, 10 Up To 400 Million Cd19 Car-positive Viable T Cells,… | 2 | $459,112.50 | $2,937,060.00 | $1,825,740.00 |
nat. median $319,951 outlier · 5.7× |
|
Q2056 HCPCS |
Ciltacabtagene Autoleucel, Up To 100 Million Autologous B-cell Maturation Antige… | 4 | $536,573.93 | $2,570,427.00 | $1,565,413.20 |
nat. median $646,415 outlier · 2.4× |
|
Q2055 HCPCS |
Idecabtagene Vicleucel, Up To 510 Million Autologous B-cell Maturation Antigen (… | 4 | $511,793.34 | $2,318,912.10 | $1,412,238.36 |
nat. median $622,450 outlier · 2.3× |
|
C9301 HCPCS |
Obecabtagene Autoleucel, Up To 400 Million Cd19 Car-positive Viable T Cells, Inc… | 1 | $959,962.50 | $1,544,287.50 | $1,405,162.50 |
nat. median $459,112 outlier · 3.1× |
|
Q2054 HCPCS |
Lisocabtagene Maraleucel, Up To 110 Million Autologous Anti-cd19 Car-positive Vi… | 4 | $500,948.74 | $2,268,056.34 | $1,381,266.75 |
nat. median $640,950 outlier · 2.2× |
|
Q2042 HCPCS |
Tisagenlecleucel, Up To 600 Million Car-positive Viable T Cells, Including Leuka… | 4 | $23.68 | $2,132,254.50 | $1,271,668.90 |
nat. median $739,258 1.7× median |
|
Q2053 HCPCS |
Brexucabtagene Autoleucel, Up To 200 Million Autologous Anti-cd19 Car Positive V… | 4 | $474,717.03 | $2,061,869.40 | $1,255,697.04 |
nat. median $591,721 outlier · 2.1× |
|
Q2041 HCPCS |
Axicabtagene Ciloleucel, Up To 200 Million Autologous Anti-cd19 Car Positive Via… | 4 | $6.22 | $1,966,642.50 | $1,172,898.50 |
nat. median $608,239 1.9× median |
|
2067 OTHER |
Afamitresgene Autoleucel | 27 | $766,766.90 | $2,019,024.40 | $809,151.00 |
nat. median $793,739 1.0× median |
|
9498 OTHER |
Ciltacabtagene Car-pos T | 26 | $565,868.90 | $1,539,641.95 | $617,032.08 |
nat. median $587,650 1.1× median |
|
9194 OTHER |
Tisagenlecleucel Car-pos | 26 | $563,698.64 | $1,484,312.01 | $594,857.87 |
nat. median $577,163 1.0× median |
|
9413 OTHER |
Lisocabtagene Car Pos T | 26 | $559,390.19 | $1,472,967.14 | $590,311.26 |
nat. median $562,201 1.1× median |
|
9422 OTHER |
Idecabtagene Vicleucel Ca | 26 | $555,291.39 | $1,462,174.32 | $585,985.89 |
nat. median $563,449 1.0× median |
|
09498 OTHER |
Ciltacabtagene Car-pos T | 2 | $570,020.11 | $587,649.60 | $578,834.85 |
nat. median $570,020 1.0× median |
|
9035 OTHER |
Axicabtagene Ciloleucel C | 26 | $529,531.24 | $1,394,343.56 | $558,801.81 |
nat. median $533,230 1.0× median |
|
09194 OTHER |
Tisagenlecleucel Car-pos | 2 | $549,535.36 | $566,531.30 | $558,033.33 |
nat. median $549,535 1.0× median |
|
09413 OTHER |
Lisocabtagene Car Pos T | 2 | $545,335.16 | $562,201.20 | $553,768.18 |
nat. median $545,335 1.0× median |
|
09422 OTHER |
Idecabtagene Vicleucel Ca | 2 | $541,339.35 | $558,081.80 | $549,710.57 |
nat. median $541,339 1.0× median |
|
09035 OTHER |
Axicabtagene Ciloleucel C | 2 | $516,226.43 | $532,192.20 | $524,209.31 |
nat. median $516,226 1.0× median |
|
9391 OTHER |
Brexucabtagene Car Pos T | 26 | $487,002.95 | $1,282,359.52 | $513,922.71 |
nat. median $492,768 1.0× median |
|
09391 OTHER |
Brexucabtagene Car Pos T | 2 | $474,766.69 | $489,450.20 | $482,108.45 |
nat. median $474,767 1.0× median |
|
J9029 HCPCS |
Intravesical Instillation, Nadofaragene Firadenovec-vncg, Per Therapeutic Dose | 5 | $61,338.53 | $888,000.00 | $405,600.00 |
nat. median $68,423 outlier · 5.9× |
|
74 APR_DRG |
Allogeneic Bone Marrow Transplant | 9 | $326,736.31 | $571,789.00 | $352,875.00 |
nat. median $170,082 outlier · 2.1× |
|
5834 APR_DRG |
Neonate With Ecmo | 8 | $335,871.71 | $419,839.64 | $352,665.30 |
nat. median $307,206 1.1× median |
|
18 MS_DRG |
Chimeric Antigen Receptor (car) T-cell And Other Immunotherapies | 21 | $314,036.10 | $1,273,072.13 | $336,467.25 |
nat. median $359,454 0.9× median |
|
286940 CDM |
Cage Spn 2.3x32.4x34.1mm | 26 | $113,159.57 | $838,219.00 | $335,287.60 |
nat. median $335,288 1.0× median |
|
J3402 HCPCS |
Injection, Remestemcel-l-rknd, Per Therapeutic Dose | 1 | $332,753.88 | $332,753.88 | $332,753.88 |
nat. median $209,753 1.6× median |
|
90288 CPT |
Botulism Immune Globulin, Human, For Intravenous Use | 1 | $294,713.96 | $416,525.16 | $329,245.80 |
nat. median $51,570 outlier · 6.4× |
Other procedures at this hospital
Browse this hospital's 42,029 published procedures. Use the slice to choose what to show, then sort or filter any column.